PlainRecalls

Shilpa Medicare Limited

Compiled from official public sources by the publisher.

6 recalls on record · Latest: Dec 16, 2020

Subscribe to new Shilpa Medicare Limited recalls (RSS)

Agency notice ledger

Federal filing book Shilpa Medicare Limited LIGHT-BOOK · SINGLE-AGENCY

#2,292 of 14,151 · 6 notices · 0.006% archive

  • BOOK 6 notices
  • RANK #2,292 of 14,151
  • SHARE 0.006% archive
  • AGENCY FDA Drug (6)
  • CAT drugs
  • CATS 2 categories
  • LATEST Dec 16, 2020
  • PHOTO 1908 Brands

Nearest notice-volume peer: 1908 Brands (0 notice gap)

Shilpa Medicare Limited accounts for about 0.006% of the 104,423-notice archive on 6 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Shilpa Medicare Limited's standing among 14,151 recalling firms

Shilpa Medicare Limited ranks 2,292nd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Shilpa Medicare Limited vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

6 2292nd of 14151 higher than 11,804 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Shilpa Medicare Limited in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Shilpa Medicare Limited holds about 0.006% of archive notices alongside 6 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Dec 16, 2020

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, Jadcherla, 509301, India, Distributed by: Armas Pharmaceuticals, Inc. Manalapan, NJ 07726 NDC 72485-201-01.
FDA Drug Moderate Dec 16, 2020

Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-203-30.
FDA Drug Moderate Dec 16, 2020

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, NDC 72606-558-01.
FDA Drug Moderate Dec 16, 2020

Docetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only, 8 mL Single Use Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, NDC 72485-216-08.
FDA Drug Moderate Dec 16, 2020

Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, Sterile, Cytotoxic Agent, Rx Only, 10 mL vial, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, Vial NDC 72485-210-01, Carton NDC 72485-210-08.
FDA Drug Moderate Dec 16, 2020

Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90.

Shilpa Medicare Limited holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (6 here).

1908 Brands 6 Abbott Molecular 6 Accriva Diagnostics, Inc. 6 Advance Medical Designs, Inc. 6 Agave Dream 6

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Aire-Master of America Inc 6 Apollo Care 6 Appco Pharma LLC 6 Aspen Biopharma Labs Pvt., Ltd. 6

Frequently Asked Questions

How many federal recall notices name Shilpa Medicare Limited? ▼
PlainRecalls indexes 6 distinct federal recall events naming Shilpa Medicare Limited, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Shilpa Medicare Limited sit among other recalling firms? ▼
Shilpa Medicare Limited ranks #2,292 of 14,151 by distinct recall-event count among 14,151 firms in this archive (83rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Shilpa Medicare Limited's notices? ▼
FDA Drug accounts for 6 of this firm's 6 indexed notices.
What product category dominates Shilpa Medicare Limited's filing book? ▼
Filings for Shilpa Medicare Limited span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Shilpa Medicare Limited: 6 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Shilpa Medicare Limited; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026